Literature DB >> 1692858

Monoclonal antibodies block murine IL-4 receptor function.

M P Beckmann1, K A Schooley, B Gallis, T Vanden Bos, D Friend, A R Alpert, R Raunio, K S Prickett, P E Baker, L S Park.   

Abstract

IL-4 is a cytokine which can induce B-lymphocyte proliferation, increase cell-surface Ia expression, and induce some activated B cells to differentiate and begin to secrete IgE. IL-4 binds specifically to a cell-surface receptor (IL-4R) on cells from a variety of lineages including T and B cells. In general both primary cells and in vitro cell lines express less than 5000 receptors per cell. Utilizing a subclone of the cytotoxic T cell line CTLL-2 expressing a high level of IL-4R, mAb against the murine IL-4R were prepared. Two mAb have been identified which have different properties. These antibodies, designated M1 and M2, recognize sequences specific to the murine IL-4R. Immunoprecipitation studies with M1 and M2 on CTLL-2 cells have identified the receptor as a Mr = 145,000 cell-surface protein. Similar results have been obtained with the recently isolated full length murine IL-4R cDNA expressed in COS-7 cells. In addition the antibodies are capable of inhibiting IL-4 binding. One antibody, M1, is also a potent inhibitor of IL-4-induced proliferation. These antibodies will be useful in dissecting a wide array of activities attributed to IL-4.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1692858

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  Decreases in IL-7 levels during antiretroviral treatment of HIV infection suggest a primary mechanism of receptor-mediated clearance.

Authors:  Jessica N Hodge; Sharat Srinivasula; Zonghui Hu; Sarah W Read; Brian O Porter; Insook Kim; Joann M Mican; Chang Paik; Paula Degrange; Michele Di Mascio; Irini Sereti
Journal:  Blood       Date:  2011-07-21       Impact factor: 22.113

2.  Thymic stromal lymphopoietin amplifies the differentiation of alternatively activated macrophages.

Authors:  Hongwei Han; Mark B Headley; Whitney Xu; Michael R Comeau; Baohua Zhou; Steven F Ziegler
Journal:  J Immunol       Date:  2012-12-28       Impact factor: 5.422

3.  Identification of markers that distinguish IgE- from IgG-mediated anaphylaxis.

Authors:  Marat V Khodoun; Richard Strait; Laura Armstrong; Noriko Yanase; Fred D Finkelman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-11       Impact factor: 11.205

4.  Interleukin 4 is important in protective immunity to a gastrointestinal nematode infection in mice.

Authors:  J F Urban; I M Katona; W E Paul; F D Finkelman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

5.  An interleukin 4 (IL-4)-independent pathway for CD4+ T cell IL-4 production is revealed in IL-4 receptor-deficient mice.

Authors:  N Noben-Trauth; L D Shultz; F Brombacher; J F Urban; H Gu; W E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

6.  The Interleukin-13 Receptor-α1 Chain Is Essential for Induction of the Alternative Macrophage Activation Pathway by IL-13 but Not IL-4.

Authors:  Faruk Sheikh; Harold Dickensheets; Joao Pedras-Vasconcelos; Thirumalai Ramalingam; Laura Helming; Siamon Gordon; Raymond P Donnelly
Journal:  J Innate Immun       Date:  2015-03-07       Impact factor: 7.349

7.  IL-4R alpha expression by bone marrow-derived cells is necessary and sufficient for host protection against acute schistosomiasis.

Authors:  De'Broski R Herbert; Tatyana Orekov; Charles Perkins; Marc E Rothenberg; Fred D Finkelman
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

8.  Erythropoietin and interleukin-2 activate distinct JAK kinase family members.

Authors:  D L Barber; A D D'Andrea
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

9.  Interleukin 4 regulates induction of sialoadhesin, the macrophage sialic acid-specific receptor.

Authors:  A S McWilliam; P Tree; S Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

10.  Vaccine-induced protection against Helicobacter pylori in mice lacking both antibodies and interleukin-4.

Authors:  Christine A Garhart; John G Nedrud; Frederick P Heinzel; Norma E Sigmund; Steven J Czinn
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.